Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$1.88B |
| 2 |
Pfizer
PFE
|
+$1.41B |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.17B |
| 4 |
Cisco
CSCO
|
+$1.1B |
| 5 |
Novartis
NVS
|
+$984M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$1.21B |
| 2 |
Adobe
ADBE
|
+$1.06B |
| 3 |
Stryker
SYK
|
+$955M |
| 4 |
Boston Scientific
BSX
|
+$695M |
| 5 |
Banco Santander
SAN
|
+$684M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.16% |
| 2 | Financials | 17.3% |
| 3 | Industrials | 10.45% |
| 4 | Healthcare | 9.91% |
| 5 | Energy | 8.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
526
Philip Morris
PM
$297B
| $2.78M | ﹤0.01% |
16,829
-1,783
| -10% | -$310K |
|
527
Victory Capital Holdings
VCTR
$6.19B
| $2.7M | ﹤0.01% |
41,214
+145
| +0.4% | +$10.1K |
|
528
SP Funds Dow Jones Global Sukuk ETF
SPSK
$650M
| $2.68M | ﹤0.01% |
149,703
+26,641
| +22% | +$484K |
|
529
American Public Education
APEI
$890M
| $2.68M | ﹤0.01% |
47,046
-1,942
| -4% | -$89K |
|
530
Nike
NKE
$61.9B
| $2.68M | ﹤0.01% |
50,644
-366,995
| -88% | -$22.3M |
|
531
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
$18.5B
| $2.64M | ﹤0.01% |
49,589
-3,490
| -7% | -$188K |
|
532
Vanguard Industrials ETF
VIS
$8.1B
| $2.63M | ﹤0.01% |
8,439
+86
| +1% | +$27.9K |
|
533
Jack Henry & Associates
JKHY
$10.9B
| $2.63M | ﹤0.01% |
+16,629
| New | +$2.85M |
|
534
Global X Robotics & Artificial Intelligence ETF
BOTZ
$3.28B
| $2.62M | ﹤0.01% |
78,851
-6,174
| -7% | -$228K |
|
|
INN
535
Summit Hotel Properties
INN
$746M
| $2.58M | ﹤0.01% |
584,667
+44,004
| +8% | +$197K |
|
536
FTAI Aviation
FTAI
$21.1B
| $2.58M | ﹤0.01% |
+10,544
| New | +$2.79M |
|
537
Baidu
BIDU
$37.7B
| $2.57M | ﹤0.01% |
23,054
+3,236
| +16% | +$439K |
|
538
Allient
ALNT
$1.49B
| $2.56M | ﹤0.01% |
43,265
-6,820
| -14% | -$430K |
|
539
Workday
WDAY
$39.6B
| $2.55M | ﹤0.01% |
19,604
-12,386
| -39% | -$1.97M |
|
540
Zymeworks
ZYME
$1.61B
| $2.54M | ﹤0.01% |
101,439
+33,242
| +49% | +$787K |
|
541
Donnelley Financial Solutions
DFIN
$1.16B
| $2.49M | ﹤0.01% |
52,832
+103
| +0.2% | +$5.05K |
|
542
iShares Semiconductor ETF
SOXX
$41.7B
| $2.48M | ﹤0.01% |
7,535
+917
| +14% | +$313K |
|
543
iShares MSCI EAFE ETF
EFA
$78B
| $2.45M | ﹤0.01% |
25,172
-7,291
| -22% | -$729K |
|
544
Shopify
SHOP
$152B
| $2.43M | ﹤0.01% |
20,503
-3,911
| -16% | -$514K |
|
545
Invesco S&P 500 Top 50 ETF
XLG
$10.6B
| $2.39M | ﹤0.01% |
43,864
-7,896
| -15% | -$454K |
|
546
iShares US Aerospace & Defense ETF
ITA
$14.2B
| $2.34M | ﹤0.01% |
10,708
-674
| -6% | -$158K |
|
547
Gorman-Rupp
GRC
$2.14B
| $2.32M | ﹤0.01% |
37,416
-1,500
| -4% | -$88.7K |
|
548
Expedia Group
EXPE
$35.4B
| $2.32M | ﹤0.01% |
10,067
-852
| -8% | -$209K |
|
549
Vanguard Total International Stock ETF
VXUS
$155B
| $2.32M | ﹤0.01% |
30,096
+6,091
| +25% | +$484K |
|
550
Wells Fargo
WFC
$261B
| $2.31M | ﹤0.01% |
29,017
-4,620
| -14% | -$397K |
|
Similar funds
Ken Fisher's Q1 2026 Portfolio in Review
As of Q1 2026, Ken Fisher held 1,133 positions worth $295B, up 0.65% from $293B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Ken Fisher's Q1 2026 filing shows 116 new, 416 increased, 461 reduced and 117 closed positions. Its largest new stake was Portfolio Building Block World Pharma and Biotech Index ETF: 28,040,859 shares worth $717M. The largest sale was Abbott, an estimated $1.21B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Financials and Industrials.
- Ken Fisher's largest Q1 2026 buy was Portfolio Building Block World Pharma and Biotech Index ETF: 28,040,859 shares worth $717M.
- Ken Fisher added most to AbbVie in Q1 2026, an estimated $1.88B increase.
- Ken Fisher's biggest Q1 2026 reduction was Abbott, cutting an estimated $1.21B.
- Ken Fisher fully exited Trip.com Group in Q1 2026, selling an estimated $175M.
- Ken Fisher's ten largest holdings make up 33% of its $295B portfolio in Q1 2026.
- Ken Fisher opened 116 new positions and closed 117 in Q1 2026.
- Ken Fisher's portfolio value rose 0.65% quarter-over-quarter to $295B.
Based on Fisher Asset Management's 13F filing for Q1 2026, filed 5 May 2026.